0001235802-19-000134.txt : 20191120 0001235802-19-000134.hdr.sgml : 20191120 20191120165206 ACCESSION NUMBER: 0001235802-19-000134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191118 FILED AS OF DATE: 20191120 DATE AS OF CHANGE: 20191120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dewey Julie D. CENTRAL INDEX KEY: 0001218011 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35065 FILM NUMBER: 191234839 MAIL ADDRESS: STREET 1: 1023 CHERRY ROAD CITY: MEMPHIS STATE: TN ZIP: 38117 FORMER NAME: FORMER CONFORMED NAME: TRACY JULIE D DATE OF NAME CHANGE: 20041008 FORMER NAME: FORMER CONFORMED NAME: TRACEY JULIE D DATE OF NAME CHANGE: 20030210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wright Medical Group N.V. CENTRAL INDEX KEY: 0001492658 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 980509600 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1229 BUSINESS ADDRESS: STREET 1: PRINS BERNHARDPLEIN 200 CITY: AMSTERDAM STATE: P7 ZIP: 1097JB BUSINESS PHONE: 901-867-4317 MAIL ADDRESS: STREET 1: 1023 CHERRY ROAD CITY: MEMPHIS STATE: TN ZIP: 38117 FORMER COMPANY: FORMER CONFORMED NAME: Tornier N.V. DATE OF NAME CHANGE: 20110201 FORMER COMPANY: FORMER CONFORMED NAME: Tornier B.V. DATE OF NAME CHANGE: 20100524 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-11-18 0 0001492658 Wright Medical Group N.V. WMGI 0001218011 Dewey Julie D. 1023 CHERRY ROAD MEMPHIS TN 38117 0 1 0 0 SVP, Chief Comm. Officer Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 16341 17.79 A 42899 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 987 17.7 A 43886 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 7324 20.75 A 51210 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 1776 22.55 A 52986 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 8232 23.93 A 61218 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 54437 20.62 A 115655 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 19997 21.24 A 135652 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 6983 27.86 A 142635 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 M 0 3892 24.49 A 146527 D Ordinary Shares, par value EUR 0.03 per share 2019-11-18 4 S 0 119969 29.4938 D 26558 D Stock Option (right to buy) 17.79 2019-11-18 4 M 0 16341 0 D 2021-10-17 Ordinary Shares 16341 0 D Stock Option (right to buy) 17.7 2019-11-18 4 M 0 987 0 D 2022-04-16 Ordinary Shares 987 0 D Stock Option (right to buy) 20.75 2019-11-18 4 M 0 7324 0 D 2022-05-09 Ordinary Shares 7324 0 D Stock Option (right to buy) 22.55 2019-11-18 4 M 0 1776 0 D 2023-04-17 Ordinary Shares 1776 0 D Stock Option (right to buy) 23.93 2019-11-18 4 M 0 8232 0 D 2023-05-14 Ordinary Shares 8232 0 D Stock Option (right to buy) 20.62 2019-11-18 4 M 0 54437 0 D 2025-10-13 Ordinary Shares 54437 0 D Stock Option (right to buy) 21.24 2019-11-18 4 M 0 19997 0 D 2026-07-19 Ordinary Shares 19997 4642 D Stock Option (right to buy) 27.86 2019-11-18 4 M 0 6983 0 D 2027-07-25 Ordinary Shares 6983 5443 D Stock Option (right to buy) 24.49 2019-11-18 4 M 0 3892 0 D 2028-07-24 Ordinary Shares 3892 8568 D Exercise and sale of vested stock options in connection with 280G tax planning. Includes 2,144 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,588 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,616 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $29.51, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. This option has fully vested. This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. /s/ Marija Nelson, attorney-in-fact 2019-11-20